There are 3397 resources available
LBA78 - Overall survival of perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy: An updated analysis of RESOLVE trial
Presenter: Xiaotian Zhang
Session: Mini oral session 1 - Gastrointestinal tumours, upper digestive
Resources:
Abstract
Slides
Webcast
1023MO - Decoding immunotherapy resistance: A novel multiparametric magnetic resonance imaging approach to stratify cancer patient outcomes
Presenter: Kinga Bernatowicz
Session: Mini oral session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Bladder preservation strategies
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: New mechanisms and drugs for the treatment of patients with sarcomas
Resources:
Slides
Webcast
The case of dental screening programmes
Presenter: Michael Heffernan
Session: The importance of secondary prevention: Early detection and screening programmes
Resources:
Slides
Webcast
1512MO - Perioperative camrelizumab (C) combined with rivoceranib (R) and chemotherapy (chemo) versus chemo for locally advanced resectable gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The first interim analysis of a randomized, phase III trial (DRAGON IV)
Presenter: Chen Li
Session: Mini oral session 1 - Gastrointestinal tumours, upper digestive
Resources:
Abstract
Slides
Webcast
1024MO - Interpretable AI-identified spatial tumor microenvironment (TME) neighborhoods associate with severe immune-related adverse events (irAE) and progressive disease (PD) in patients with melanoma treated with anti-PD-1-based therapy
Presenter: Janis Taube
Session: Mini oral session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA3
Presenter: Laura Locati
Session: Presidential 1
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Marta Sbaraglia
Session: New mechanisms and drugs for the treatment of patients with sarcomas
Resources:
Webcast
Discussion
Presenter: All Speakers
Session: The importance of secondary prevention: Early detection and screening programmes
Resources:
Slides
Webcast